Clinical Trial Update: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 [Phase 1, Phase 2]

View source ↗

Summary

This entry describes an ongoing Phase 1/Phase 2 clinical trial of DYNE-101 in Myotonic Dystrophy Type 1 assessing safety, tolerability, pharmacodynamics, effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• DYNE-101

Snippet

Sponsor: Dyne Therapeutics | Conditions: Myotonic Dystrophy Type 1 (DM1) | Phase 1, Phase 2 | Status: RECRUITING